
1 patent(s) in this week's alert:
Assignee Summary:| Patents | Owner |
| 1 | Vettore |
| Patents | Class Code |
| 1 | C07D [HETEROCYCLIC COMPOUNDS (macromolecular compounds C08) [...] |
Details on individual patents:
| #12492171 | Heterocyclic inhibitors of MCT4 |
| Applied: | 02/22/2022, #17/652022 |
| Issued: | 12/09/2025, [1386 days App to Issue] Normal range: (525 to 1649) |
| Pat Class: | C07D [HETEROCYCLIC COMPOUNDS (macromolecular compounds C08) [...] In this class there are; 44422 patents, 2938 companies, and 38795 inventors in 221 other Metros. |
| Claims: | 9; Normal range for this patent class is (4 to 26) |
| Assignee: | Vettore (San Francisco, CA) with total patents of: 7 (since 2005) |
| Counsel: | Firm: Global Patent Group Inc. |
| 1st Invent: | John McCall (Boca Grande, FL) |
| Inventors: | Genders: F=1, M=2 |
| Abstract: 2000 char max | Methods of inhibition MCT4 activity in a human or animal subject are also provided. |
| | |